The landscape of dementia prognosis has evolved significantly with the advent of sophisticated biomarkers, such as amyloid PET scans, tau imaging, and blood-centered tests that may detect Alzheimer's pathology many years in advance of signs or symptoms arise. Although these technological advances characterize outstanding development in comprehending neurodegenerative health conditions, https://chesterb097blv7.wikiusnews.com/user